Displaying 1 - 20 of 151 results
Released Company Title Industry Topic
26 May 2020
08:00 CEST
LYSOGENE NOVASEP et LYSOGENE annoncent leur nouvelle collaboration pour le développement et la production du produit de thérapie génique dans le traitement de la gangliosidose à GM1 20103010 Biotechnology Other subject
26 May 2020
08:00 CEST
LYSOGENE NOVASEP and LYSOGENE Announce their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product 20103010 Biotechnology Other subject
20 May 2020
18:00 CEST
LYSOGENE Lysogene : Assemblée générale ordinaire annuelle et extraordinaire du 26 juin 2020 Biotechnology General meeting / Board Meeting
20 May 2020
18:00 CEST
LYSOGENE Lysogene: Annual Ordinary and Extraordinary General Meeting of 26 June 2020 Biotechnology General meeting / Board Meeting
14 May 2020
08:00 CEST
LYSOGENE Lysogene Announces Presentations at Upcoming Meetings Biotechnology Meetings / events
14 May 2020
08:00 CEST
LYSOGENE Lysogene annonce des présentations à l’occasion de plusieurs conférences à venir Biotechnology Meetings / events
13 May 2020
18:00 CEST
LYSOGENE Kepler Cheuvreux initie la couverture de Lysogene Biotechnology Share history
13 May 2020
18:00 CEST
LYSOGENE Kepler Cheuvreux Initiates Coverage of Lysogene Biotechnology Share history
30 Apr 2020
18:00 CEST
LYSOGENE Lysogene Announces Filing of 2019 Universal Registration Document Biotechnology Legal
30 Apr 2020
18:00 CEST
LYSOGENE Lysogene Publie son Document d’Enregistrement Universel 2019 Biotechnology Legal
29 Apr 2020
08:00 CEST
LYSOGENE Lysogene Reports Its Cash Position as of 31 March 2020 Biotechnology Sales
29 Apr 2020
08:00 CEST
LYSOGENE Lysogene annonce sa position de trésorerie au 31 mars 2020 Biotechnology Sales
22 Apr 2020
07:30 CEST
LYSOGENE Lysogene annonce ses résultats annuels 2019 et fait le point sur ses activités Biotechnology Income
22 Apr 2020
07:30 CEST
LYSOGENE Lysogene Reports Full Year 2019 Financial Results and Provides Operational Update Biotechnology Income
16 Mar 2020
08:00 CET
LYSOGENE Lysogene annonce la date de son Assemblée générale des actionnaires 2020 et modifie son calendrier financier Biotechnology General meeting / Board Meeting
16 Mar 2020
08:00 CET
LYSOGENE Lysogene Announces the Date of Its 2020 General Shareholders’ Meeting and Amends Its Financial Calendar Biotechnology General meeting / Board Meeting
12 Mar 2020
08:30 CET
LYSOGENE Lysogene réalise une augmentation de capital de 7,7 millions d’euros menée par OrbiMed, investisseur de premier plan dans la santé, et par son actionnaire et partenaire Sarepta Biotechnology Change in Capital
12 Mar 2020
08:30 CET
LYSOGENE Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta Biotechnology Change in Capital
03 Mar 2020
08:00 CET
LYSOGENE Lysogene met en œuvre un contrat de liquidité avec Kepler Cheuvreux Biotechnology Share history
25 Feb 2020
07:30 CET
LYSOGENE Lysogene Receives FDA Fast Track Designation for LYS-SAF302 Gene Therapy in MPS IIIA Biotechnology Products and services